BACKGROUND: Veterans Health Administration (VHA) databases are used extensively to study racial/ethnic disparities; however, these databases may not capture all care received by VHA patients. OBJECTIVES: We examined the extent to which accounting for non-VHA care changed conclusions about racial/ethnic disparities for VHA patients with diabetes. METHODS: Using a cross-sectional observational study, we analyzed a national sample of noninstitutionalized Hispanic (n = 5931), black (n = 24,670), and white (n = 149,222) VHA patients with diabetes who were at least 65 years of age for receipt of annual HbA1c testing, low-density lipoprotein (LDL) cholesterol testing, or eye examination from VHA and Medicare administrative files. RESULTS: In VHA alone data, adjusting for patient characteristics, Hispanic and black patients were as likely as white patients to receive HbA1c testing (odds ratio 1.06 [95% confidence interval 0.99-1.13] and 1.04 [1.00-1.07], respectively), and more likely to receive eye examinations (1.31 [1.24-1.38] and 1.33 [1.29-1.37], respectively). Hispanic patients were equally likely (1.01 [0.95-1.07]) and black patients were less likely (0.81 [0.79-0.84]) to receive LDL testing versus white patients. In VHA plus Medicare data, Hispanic and black patients were less likely than white patients to receive HbA1c (0.76 [0.71-0.82] and 0.83 [0.80-0.87], respectively) and LDL testing (0.84 [0.79-0.90] and 0.70 [0.68-0.72], respectively), and equally likely to receive eye examinations (0.91 [0.86-0.96]) and 0.98 [0.95-1.01]), respectively). Accounting for VHA facility had little effect on results. CONCLUSIONS: Restricting to VHA data masks racial/ethnic disparities in care of VHA patients. VHA researchers must be aware and supplement VHA data with other sources whenever possible.
BACKGROUND: Veterans Health Administration (VHA) databases are used extensively to study racial/ethnic disparities; however, these databases may not capture all care received by VHA patients. OBJECTIVES: We examined the extent to which accounting for non-VHA care changed conclusions about racial/ethnic disparities for VHA patients with diabetes. METHODS: Using a cross-sectional observational study, we analyzed a national sample of noninstitutionalized Hispanic (n = 5931), black (n = 24,670), and white (n = 149,222) VHA patients with diabetes who were at least 65 years of age for receipt of annual HbA1c testing, low-density lipoprotein (LDL) cholesterol testing, or eye examination from VHA and Medicare administrative files. RESULTS: In VHA alone data, adjusting for patient characteristics, Hispanic and black patients were as likely as white patients to receive HbA1c testing (odds ratio 1.06 [95% confidence interval 0.99-1.13] and 1.04 [1.00-1.07], respectively), and more likely to receive eye examinations (1.31 [1.24-1.38] and 1.33 [1.29-1.37], respectively). Hispanic patients were equally likely (1.01 [0.95-1.07]) and black patients were less likely (0.81 [0.79-0.84]) to receive LDL testing versus white patients. In VHA plus Medicare data, Hispanic and black patients were less likely than white patients to receive HbA1c (0.76 [0.71-0.82] and 0.83 [0.80-0.87], respectively) and LDL testing (0.84 [0.79-0.90] and 0.70 [0.68-0.72], respectively), and equally likely to receive eye examinations (0.91 [0.86-0.96]) and 0.98 [0.95-1.01]), respectively). Accounting for VHA facility had little effect on results. CONCLUSIONS: Restricting to VHA data masks racial/ethnic disparities in care of VHA patients. VHA researchers must be aware and supplement VHA data with other sources whenever possible.
Authors: Nancy Pandhi; Maureen A Smith; Amy J H Kind; Jennifer R Frytak; Michael D Finch Journal: Cerebrovasc Dis Date: 2009-01-29 Impact factor: 2.762
Authors: Carolyn T Thorpe; Joshua M Thorpe; Amy J H Kind; Christie M Bartels; Christine M Everett; Maureen A Smith Journal: J Am Geriatr Soc Date: 2012-03-16 Impact factor: 5.562
Authors: Christie M Bartels; Amy J H Kind; Carolyn T Thorpe; Christine M Everett; Rachel J Cook; Patrick E McBride; Maureen A Smith Journal: Semin Arthritis Rheum Date: 2012-03-16 Impact factor: 5.532
Authors: Raya Elfadel Kheirbek; Ali Fokar; Nawar Shara; Leakie K Bell-Wilson; Hans J Moore; Edwin Olsen; Marc R Blackman; Maria D Llorente Journal: J Am Geriatr Soc Date: 2017-04-19 Impact factor: 5.562
Authors: R Neal Axon; Mulugeta Gebregziabher; Carrae Echols; Gregory Gilbert Msph; Leonard E Egede Journal: J Gen Intern Med Date: 2011-06-14 Impact factor: 5.128
Authors: Jonathan G Shaw; Vilija R Joyce; Susan K Schmitt; Susan M Frayne; Kate A Shaw; Beate Danielsen; Rachel Kimerling; Steven M Asch; Ciaran S Phibbs Journal: Health Serv Res Date: 2018-09-10 Impact factor: 3.402